Laboratory Software Data Migration and Validation Guide

Migration must preserve scientific meaning

Moving laboratory data is not equivalent to copying rows between databases. A result is meaningful because it is connected to a sample, subject or source, collection event, container, custody history, preparation, instrument, method, calibration context, units, analyst, calculation, quality review, amendment, and study or operational purpose. If those relationships are flattened or silently reinterpreted, the new system may contain all expected counts while producing unreliable science.

Begin by defining the laboratory and decision boundary. A research collaboration platform, academic core facility, environmental laboratory, clinical research operation, and regulated quality-control laboratory can have very different record, validation, privacy, retention, and approval responsibilities. Identify organizations, jurisdictions, funding or contractual commitments, applicable regulations, quality systems, institutional policies, data-use agreements, and qualified scientific, quality, privacy, legal, records, and information-security owners. They must decide which obligations and acceptance standards apply.

Set a measurable migration outcome: authorized users can find a sample, reconstruct its lineage, interpret its result using the correct method and units, distinguish original from corrected data, verify approvals, reproduce material calculations where required, and export the record with its context. “All data imported successfully” is only a transport metric.

Inventory sources before designing the destination

Create a source register covering the existing LIMS, electronic laboratory notebooks, instrument software, shared drives, spreadsheets, databases, paper indexes, identity directories, sample-label systems, repositories, analysis pipelines, and external collaborator transfers. For each source, record owner, technical contact, version, location, size, formats, identifiers, time span, sensitivity, retention, backup state, access method, known defects, and downstream consumers.

Profile the data without changing it. Measure record counts, nulls, duplicates, invalid relationships, unit variants, encoding, timestamp and timezone behavior, identifier patterns, attachment types, orphan files, unexpected statuses, and values outside plausible ranges. Preserve representative examples of difficult history: renamed studies, merged subjects, relabeled samples, aliquots, reruns, amended results, withdrawn consent where relevant, method revisions, instrument replacement, failed quality controls, and records created during outages.

Inventory meaning as well as fields. Ask how a “sample date,” “result,” “approved,” “version,” or “deleted” value was actually used in each system. Two columns with the same label can represent different events, and two differently named columns may represent one governed concept. Record ambiguities as decisions with qualified owners rather than letting a transformation script guess.

Define the canonical record and provenance model

Model durable entities and relationships before mapping columns. A useful boundary may distinguish project or study, protocol, participant or source, visit or collection event, specimen, container, aliquot, chain-of-custody event, test request, method version, run, instrument, raw file, observation, calculated result, quality event, review, approval, amendment, and published dataset. Not every laboratory needs every entity, but collapsing them into a single sample record often destroys lineage.

Assign stable identifiers that do not depend on a mutable label or database sequence. Preserve every legacy identifier with its source namespace. Define parent-child and derivation relationships, units, controlled vocabularies, effective dates, version rules, and deletion or withdrawal semantics. Keep raw observations separate from normalized values, calculations, interpretations, and decisions.

Provenance should answer where a value originated, when it was produced, by which instrument or person, using which method and software version, what transformed it, whether it was corrected, who reviewed it, and which downstream results depend on it. The NIH Data Management and Sharing Policy emphasizes prospective planning for management, preservation, and appropriate sharing of scientific data. Even when that policy does not apply, designing for reuse and verification improves migration quality.

Establish the regulated and validation boundary

Do not apply one compliance label to every laboratory system. FDA guidance explains that 21 CFR Part 11 applies to certain electronic records maintained or submitted under FDA record requirements. FDA also recommends documented evidence that a system is fit for its intended use, while allowing a risk-based approach within the guidance's scope. Qualified quality and regulatory roles must determine applicability and validation depth for the actual intended use.

Write an intended-use statement and identify functions that create, modify, maintain, archive, retrieve, or transmit records within the approved boundary. Connect user requirements to risks, controls, tests, evidence, deviations, and approval. Include identity, authorization, electronic signatures where used, audit trails, record retention, accurate copies, time behavior, backup, restoration, and change control as required by the organization's obligations.

FDA's data-integrity guidance states an expectation that CGMP data be reliable and accurate and recommends meaningful risk-based strategies. It discusses complete data, metadata, audit trails, access, review, retention, and backup. Do not strip metadata or import only current values when the source history is necessary to establish authenticity, context, or reconstruction. If history cannot be migrated faithfully, preserve the original system or a controlled archive and document the boundary honestly.

Build a traceable transformation pipeline

Preserve immutable source extracts with checksums, access controls, extraction time, software version, and responsible operator. Never make the only migration copy a working file that scripts modify in place. Separate extraction, staging, normalization, validation, loading, and reconciliation so each step can be repeated and explained.

Create a version-controlled mapping specification for every included field and relationship. Record source, destination, transformation, code conversion, unit conversion, default behavior, rejection rule, precision, timezone, null meaning, owner, and test. Avoid silent defaults. “Unknown,” “not collected,” “not applicable,” “not yet received,” and an empty field may carry different scientific meaning.

Use deterministic transformations where possible. Store the pipeline version, configuration, execution identifier, input checksum, output checksum, warnings, rejects, and reconciliation results. Make re-running safe by using stable keys and idempotent loading. For calculated values, preserve the original result and method context before deciding whether to recalculate; a new calculation engine can produce a different answer even from identical inputs.

Validate at several levels

File and row counts are necessary but insufficient. Validate structure: required fields, types, relationships, uniqueness, referential integrity, and attachments. Validate semantics: units, vocabularies, statuses, date meaning, method version, precision, and derivation. Validate behavior: search, sample lineage, result review, amendment, export, access, and reporting. Validate operations: monitoring, backup, restore, failure recovery, and support.

Reconcile totals by meaningful partitions such as study, source system, year, status, sample type, method, and record class. Compare sums and distributions where scientifically appropriate. Use checksums for unchanged files, targeted field comparisons for transformed records, and end-to-end lineage tests for representative and high-consequence cases. Every mismatch should be resolved, accepted by an authorized owner with rationale, or placed in an accountable exception queue.

Use risk-based sampling only after automated whole-population checks. Select samples deliberately: oldest and newest records, every legacy version, maximum relationships, unusual encodings, corrected results, rare units, withdrawn or restricted data, large attachments, leap days, daylight-saving boundaries, and records tied to known incidents. Random samples alone may miss the exact conditions most likely to break.

Protect privacy and access during migration

A temporary staging area can become the least controlled copy of the laboratory's most sensitive data. Minimize extracted fields, separate direct identifiers where appropriate, encrypt transfers and storage, restrict accounts, record access, rotate credentials, scan approved file types, set retention, and destroy temporary copies after authorized acceptance. Do not move production datasets through personal drives, consumer messaging, or unmanaged workstations.

For human-participant data, NIH supplemental guidance emphasizes that effective data stewardship and participant privacy should be addressed together. Determine consent, authorization, data-use, Tribal, institutional, contractual, and legal constraints before migration or sharing. Use qualified review for de-identification or controlled-access decisions; removing names alone may not make a rich scientific dataset non-identifiable.

Test authorization after loading, including organization, study, project, role, assignment, consent or use limitation, embargo, and record-state boundaries. Verify APIs, search indexes, exports, reports, backups, support tools, and analytics—not only visible pages. A correct record shown to the wrong person is a migration failure.

Rehearse cutover and rollback

Run at least one full-volume rehearsal using the same pipeline, infrastructure, accounts, and approximate timing planned for production. Measure extraction duration, load rate, index creation, reconciliation, validation, user testing, backup, and rollback. Exercise malformed files, network interruption, insufficient storage, failed batches, duplicate replay, unavailable source, and a transformation defect discovered after loading.

Define a change-freeze or delta strategy. If the source remains active, decide how records created or amended after the initial extract will be captured, sequenced, and reconciled. Specify which system is authoritative at every point, how users are informed, and how downstream integrations behave. Parallel operation without a clear authority model creates two divergent scientific records.

Set objective go/no-go criteria: critical reconciliation complete, accepted exceptions documented, representative workflows passed, access verified, performance adequate, backups and restore proven, support staffed, training complete, and qualified owners signed off. Rollback must include changes performed after cutover, not merely restoring yesterday's database.

Preserve archive, export, and ownership

Decide whether to migrate complete history, migrate active records and retain a controlled archive, or preserve source systems read-only for a defined period. The choice depends on intended use, retrieval needs, retention, legal holds, validation, cost, and technical feasibility. An archive must remain readable, searchable, access-controlled, backed up, and testable; a powered-off server with undocumented software is not a preservation strategy.

Require usable exports of records, metadata, relationships, controlled vocabularies, attachments, raw files where included, audit history, approvals, identifiers, and access context. Document formats and schemas. Test retrieval without vendor assistance and preserve viewers or conversion plans for proprietary formats where necessary.

The laboratory or accountable organization should control or be able to transfer repositories, cloud accounts, domains, encryption keys, integration credentials, deployment automation, observability, backups, transformation code, mapping specifications, validation evidence, and operating documentation. NIST's Secure Software Development Framework supports protecting source and build components and responding to vulnerabilities throughout the lifecycle; those practices matter for migration tools as well as the destination application.

Use an evidence-based migration checklist

Before approving migration, confirm the intended use and regulatory boundary; source inventory; data owners; canonical model; identifier strategy; provenance; mapping specification; immutable extracts; privacy controls; transformation evidence; whole-population reconciliation; risk-based samples; authorization; audit history; attachments; performance; backup and restore; cutover; delta handling; rollback; archive; exports; support; and named acceptance authority.

The laboratory information management system requirements checklist helps define the destination boundary. Use the software data migration planning checklist for the broader program and the software acceptance testing guide to organize evidence. Share laboratory type, intended use, source systems, record volume, privacy or regulatory context, integrations, and target outcome through the project questionnaire, or use quick contact for a focused migration review.

Authoritative references

• FDA Part 11 Electronic Records and Electronic Signatures guidance
• FDA Data Integrity and Compliance With Drug CGMP guidance
• NIH Data Management and Sharing Policy
• NIH guidance on protecting privacy when sharing participant data
• NIST Secure Software Development Framework 1.1

Related software planning guides

• Biotechnology Research Workflow Platform Requirements
• Laboratory Information Management System Requirements Checklist
• Laboratory Workflow System Cost: A Lifecycle Planning Guide